GOOD, GREG – Trademark Portfolio
Entity Type: 01
GOOD, GREG holds 34 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 28 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 5 Nice Classification classes. Currently, 14 trademarks are registered. Notable registered marks include SEA VEG, FARMASEA, UNVITAMIN, SUPER SEA VEG, and SEA VEGGY TAILS. The owner is based in SCOTTSDALE, AZ.
6202 EAST COCHISE ROAD
SCOTTSDALE, AZ 85253
Showing of trademarks Trademarks
Trademark Classifications
GOOD, GREG's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Frequently Asked Questions
How many trademarks does GOOD, GREG have?
GOOD, GREG has 34 U.S. trademarks filed with the USPTO. Of these, 14 registered, 6 abandoned, 14 cancelled.
What trademark classes does GOOD, GREG file in?
GOOD, GREG files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 25 (Clothing), Class 8 (Hand Tools), Class 28 (Toys & Sporting Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are GOOD, GREG's most well-known trademarks?
GOOD, GREG's registered trademark portfolio includes well-known marks such as SEA VEG, FARMASEA, UNVITAMIN, SUPER SEA VEG, and SEA VEGGY TAILS. These are among 14 currently registered trademarks in the portfolio.
What is GOOD, GREG's trademark registration success rate?
GOOD, GREG has a 41% trademark registration rate, with 14 out of 34 resolved applications resulting in successful registration. Currently, 0 applications are pending review.